Ra Capital Management as of Dec. 31, 2015
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 37 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Achillion Pharmaceuticals | 12.0 | $121M | 11M | 10.79 | |
| Wave Life Sciences (WVE) | 11.2 | $113M | 7.1M | 15.95 | |
| Dyax | 10.1 | $102M | 2.7M | 37.62 | |
| Axovant Sciences | 8.9 | $90M | 5.0M | 18.03 | |
| Aclaris Therapeutics (ACRS) | 6.8 | $69M | 2.6M | 26.94 | |
| Tg Therapeutics (TGTX) | 3.3 | $34M | 2.8M | 11.93 | |
| Zogenix | 3.3 | $33M | 2.3M | 14.74 | |
| BioCryst Pharmaceuticals (BCRX) | 3.2 | $32M | 3.1M | 10.32 | |
| Ascendis Pharma A S (ASND) | 3.0 | $31M | 1.7M | 18.32 | |
| Regulus Therapeutics | 3.0 | $30M | 3.5M | 8.72 | |
| Coherus Biosciences (CHRS) | 2.9 | $29M | 1.3M | 22.96 | |
| Dicerna Pharmaceuticals | 2.9 | $29M | 2.4M | 11.87 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 2.3 | $24M | 858k | 27.50 | |
| Blueprint Medicines (BPMC) | 2.3 | $23M | 878k | 26.34 | |
| Proteon Therapeutics | 2.3 | $23M | 1.5M | 15.51 | |
| Strongbridge Bioph shs usd | 2.0 | $20M | 2.7M | 7.60 | |
| Sangamo Biosciences (SGMO) | 2.0 | $20M | 2.2M | 9.13 | |
| Aquinox Pharmaceuticals | 2.0 | $20M | 1.6M | 12.48 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 2.0 | $20M | 1.2M | 17.16 | |
| Alcobra | 1.9 | $19M | 3.0M | 6.28 | |
| Arena Pharmaceuticals | 1.6 | $17M | 8.7M | 1.90 | |
| Global Blood Therapeutics In | 1.5 | $15M | 457k | 32.33 | |
| Aimmune Therapeutics | 1.4 | $15M | 790k | 18.45 | |
| Dimension Therapeutics | 1.2 | $12M | 1.1M | 11.28 | |
| Ardelyx (ARDX) | 1.0 | $10M | 571k | 18.12 | |
| Pronai Therapeutics | 0.9 | $9.1M | 605k | 15.04 | |
| Natera (NTRA) | 0.8 | $8.5M | 784k | 10.80 | |
| Tenax Therapeutics | 0.8 | $7.8M | 2.4M | 3.28 | |
| Vitae Pharmaceuticals | 0.6 | $5.8M | 321k | 18.10 | |
| Zynerba Pharmaceuticals | 0.5 | $5.1M | 507k | 10.07 | |
| Applied Genetic Technol Corp C | 0.5 | $4.8M | 236k | 20.40 | |
| Nivalis Therapeutics | 0.5 | $4.7M | 613k | 7.74 | |
| Akari Therapeutics | 0.4 | $3.8M | 264k | 14.50 | |
| Arca Biopharma | 0.4 | $3.6M | 778k | 4.65 | |
| Derma Sciences | 0.3 | $2.9M | 641k | 4.57 | |
| Neuroderm Ltd F | 0.2 | $2.5M | 145k | 17.05 | |
| Ampliphi Biosciences | 0.0 | $213k | 54k | 3.97 |
